Viking Therapeutics, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings reports show how the company is performing financially and help you track progress.
Earnings announcements let you see if the company made money or lost money that quarter.
Directors make key decisions for the company, so knowing who they are matters to shareholders.
Quarterly earnings reports show how the company is performing financially and help you track progress.
Earnings announcements let you see if the company made money or lost money that quarter.
Annual earnings reports show how the company performed over the whole year and its financial health.
Year-end earnings announcements show the company's total performance and help you understand its financial strength.
Stocky reads Viking Therapeutics, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Viking Therapeutics, Inc.'s most recent tracked filing was a 10-Q on 29 Jul 2026: Filed second quarter 2026 financial results and corporate update.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.